HIV Vaccines
Antibody-Based Therapies Target Cell Interaction
Published in AIDS Weekly, February 21st, 2000
"The push for an effective AIDS vaccine has been hampered, in part, by the inability to elicit a potent neutralizing antibody response against genetically diverse HIV-1 isolates," said K. Salzwedel and colleagues from the U.S. National Institutes of Health, Maryland. "Two human monoclonal antibodies (mAbs), 17b and 48d, have been described that bind a conserved region of gp120, overlapping the coreceptor-binding site, that becomes more exposed upon binding of Env to CD4. However, these mAbs neutralize virus only...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-02-21)
More Articles from AIDS Weekly
- HIV Vaccines
Patterns and Viral Site Change Direction of Vaccine and Treatment Research - HIV Vaccines
HIV-1 gp140 Protein Has Potential Use in Multivalent Vaccine - Herbal Medicine
St. John's Wort Can Interact Dangerously with HIV and Heart Transplant Drugs - Transmission
Study Shows Breast Milk and Semen Overcome Natural Defense Against Oral HIV Transmission - Violence
HIV Infected Adults Face High Rates of Partner Violence - AIDS Therapies
Agenerase Levels in Bloodstream Raised by Ritonavir - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
